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Monophosphines prepared by iron catalysed hydrophosphination have been used as pro-ligands in iron 
catalysed Negishi cross-coupling of alkyl bromides and diphenyl zinc reagents. The cross-coupling has 
been investigated with monophosphines with varying electronic properties and we find the simplest, 
unsubstituted phosphine to offer the optimum reaction conditions (both in terms of yield of diarylmethane 
product and cost-effectiveness of the phosphine). In situ catalyst generation from monophosphine and FeCl2 10 
was used in catalysis; however, preparation of a discrete homonuclear iron complex was also achieved and 
this four-coordinate iron-phosphine complex was isolated and used in catalysis. 
Introduction 
 Catalysis with first row transition metals (FRTMs) is currently 
undergoing a period of intense activity, with many elegant 15 
transformations being directed towards the synthesis of small 
organic molecules.1 Justifiably the reasons for this attention rest 
with the acute need to harness these inexpensive, environmentally 
benign and non-toxic metals with a growing global focus on 
sustainable green synthetic protocols. Catalytic C–C bond forming 20 
reactions with the FRTMs is crucial, for example, the desire to 
generate high value products by replacing transformations 
traditionally carried out by the Platinum Group Metals (PGMs) is 
a key target, however, tuning a FRTM catalyst to undertake a two-
electron process rather than the more favourable one-electron 25 
transformation is a challenge. Traditional PGM cross-couplings 
are used on an industrial scale and as a result, their mechanistic 
details are generally well-understood, in contrast mechanistic 
understanding of FRTM catalysis is exacting, not least because 
reactions with metals such as iron invariably proceed with 30 
paramagnetic pre-catalysts or paramagnetic reactive intermediates. 
However, the FRTMs often undertake catalysis complimentary to 
that of the PGMs. A classic example is iron catalysed cross-
coupling of organometallic reagents and alkyl halides:2 alkyl 
halides containing halogen-substituted aromatic rings are also 35 
tolerated by iron catalysts whereas the palladium catalysed 
reaction is likely to lead to competitive aryl-aryl bond forming 
reactions.3  
We have recently demonstrated the synthetic utility of an Fe(III) 
salen complex (1) in the hydrophosphination (HP) of styrenes 40 
(Scheme 1a).4 During these studies we proved that the ethyl-
monophosphine product (2) is a useful pro-ligand for iron-
catalysed Negishi cross-coupling (Scheme 1b). To our surprise, 
although the synthesis of ethyl-monophosphines is routinely used 
as a synthetic benchmark in TM catalysed HP chemistry,5 to the 45 
best of our knowledge, we are the first to develop a synthetic 
application for these phosphines. On top of this, the iron catalysed 
Negishi cross-coupling of aryl zinc reagents and benzyl bromides 
often relies on the use of diphosphines:2i although these are 
commercially available, many such as dpbz are prohibitively 50 
expensive and have limitations in terms of steric and electronic 
variability. Elegant advances have been made with more simple 
diphosphines,2r,6 but reports of iron catalysed Negishi cross-
coupling with monophosphines is limited and, given the principal 
rationale for developing iron catalysis is often based on cost 55 
effectiveness, we envisaged that use of an inexpensive phosphine 
ligand would enhance the field. We herein report the extended 
scope of this synthetic methodology using simple 
monophosphines. 
Scheme 1. a) We have previously demonstrated that a simple, air-stable Fe 60 
(III) complex (1) can catalyse the hydrophosphination of styrenes; b) 
preliminary results showing phosphine 2 can be employed as a ligand for 
Fe-catalysed Negishi cross-coupling. 
Results and discussion 
Tertiary phosphine 2 was prepared on a large scale using the HP 65 
techniques developed in our laboratory. In our hands, we find this 
to be the most convenient, reproducible and cleanest route to this 
class of phosphine. Attempted SN2 reaction of HPPh2 with (2-
bromoethyl)benzene in the absence and presence of base7 often led 
 2  |  Journal Name, [year], [vol], 00–00 This journal is © The Royal Society of Chemistry [year] 
to low yield of product and/or complex mixtures. Using controlled 
drop-wise addition, varying the order of addition, using low 
temperatures and/or reducing reactions times did not reduce the 
complexity of the product mixture. Use of a stoichiometric amount 
of LiHMDS, HPPh2 and (2-bromoethyl)benzene was effective 5 
giving 72% of 2 after 4 h at RT, however, the need for a 
stoichiometric organometallic reagent, which results in a 
stoichiometric amount of waste by-product, is somewhat less 
attractive. Our HP route led to high isolated yield of product on a 
large  scale (90%; 4.8 mmol diphenylphosphine and 6.7 mmol 10 
styrene) and the catalyst loading could be further lowered from 0.5 
mol% to 0.2 mol% with the reaction still being carried out at RT. 
Increasing the scale of the reaction is also beneficial in removing a 
minor impurity observed to co-elute with 2.8  
Following the optimised synthesis of 2, we decided to explore the 15 
potential of other phosphines to facilitate this transformation. 
Three additional phosphines (3 to 5) with variable electronic 
properties were prepared using the Fe-catalysed HP methodology 
with little deviation in yield (Figure 1). 
 20 
 
 
 
 
 25 
 
 
Fig.  1. Phosphines prepared using HP catalysed by 1 for use in Fe-
catalysed Negishi cross-coupling. HP carried out on a 4.8 mmol HPPh2 
scale. 30 
Using the coupling of diphenyl zinc (prepared by the 
transmetallation of phenylmagnesium bromide with zinc chloride) 
and benzyl bromide as our standard Negishi reaction we first 
investigated the effect of solvent. In situ catalyst preparation was 
also used in the first instance. Similar to other reports in the 35 
literature, use of THF as the principal solvent is deleterious to 
reactivity,2d giving only 18% diphenylmethane product (6a, Table 
1, Entry 1). Pre-reduction, whereby FeCl2 and the phosphine are 
first added to the ZnCl2 solution followed by PhMgBr, with benzyl 
bromide added last, further lowers the yield of 6a to 8% (Entry 2). 40 
In our preliminary report,5 toluene was used as the solvent of 
choice and an unoptimised loading of 30 mol% 2, it is clear that 
toluene is best suited for this reaction based on these results and 
other reports in the area.[2d,i,q] The use of 30 mol% phosphine also 
proves to be fundamental to the formation of 6a: the spectroscopic 45 
yield of 6a drops to 49% when the ligand loading is halved to 15 
mol% (compare Entries 3 and 5). A mercury drop test demonstrates 
that the reaction mixture is not heterogenous in nature, with only a 
minor reduction in yield being observed (Entry 4).9 With optimised 
solvent conditions in hand we note that the electronic properties of 50 
the phosphine also have an effect on catalysis: use of an electron 
rich phosphine (3) leads to a reduction in spectroscopic yield of 6a 
to 37% (Entry 6). A moderately electron poor phosphine (4, Entry 
7) provides a modest yield of 6a, but is still lower than that 
observed with 2. Introduction of a strongly electron withdrawing 55 
p-CF3 group increases the yield of 6a further (Entry 8), but does 
not offer any substantial benefits over unsubstituted variant 2. Due 
to the minor difference in yield when comparing phosphines 2 and 
5, along with the inexpensive nature of the unsubstituted styrene 
used to make 2, we proceeded to optimise the reaction conditions 60 
using 2. Although the predominant aim of this research is to 
develop an application for a commonly synthesised yet largely 
ignored phosphorus motif, we proceeded to test common 
phosphines in order to illustrate wider options in this area of 
Negishi cross-coupling. PCy3 is a poor ligand in the standard 65 
reaction (Entry 10), whilst PPh3 is comparable to 2 (Entry 11). This 
is in stark contrast to results obtained with PPh3/Fe(acac)3.2i 
Table 1: Optimisation of iron-catalysed Negishi cross-coupling 
 
 70 
 
 
Entry Phosphine Solvent Spec. Yield (%)a 
1 0.3 mmol 2 THF 18 
2 0.3 mmol 2 THF with pre-reduction 8 
3 0.3 mmol 2 toluene 74 
4b 0.3 mmol 2 toluene, Hg 71 
5 0.15 mmol 2 toluene 49 
6 0.3 mmol 3 toluene 37 
7 0.3 mmol 4 toluene 51 
8 0.3 mmol 5 toluene 76 
9 ligand-free toluene 16 
10 0.3 mmol PCy3 toluene 29 
11 0.3 mmol PPh3 toluene 71 
General reaction conditions: PhMgBr (670 μL, 2 mmol, 2 eq; 3 M in Et2O), 
ZnCl2 (136 mg, 1 mmol) in THF (0.5 mL) then solvent (4 mL) and benzyl 
bromide (1 mmol, 1 eq). FeCl2 (6 mg, 5 mol%) and phosphine in solvent 75 
(3 mL). aDetermined by 1H NMR using 1,3,5-trimethoxybenzene as an 
analytical standard (see experimental section for methodology). bThree 
drops of Hg added to the reaction mixture (~1.5 mmol). 
We questioned whether a discrete, mononuclear iron complex 
could be synthesised using phosphine 2. Reaction of two 80 
equivalents of 2 with FeCl2·THF1.5 in dry, degassed acetone leads 
to the formation of a white powder which is confirmed to have the 
structure 7 by X-ray crystallography (Figure 2) and elemental 
analysis. The single crystal X-ray structure of 7 shows an 
approximate C2V arrangement of two phosphine and two chloride 85 
ligands around the metal centre. It is a highly air-sensitive solid 
which can only be prepared in acetone, where attempted synthesis 
in THF or CH2Cl2 simply leads to precipitation of nanoparticulate 
iron. Interestingly, once synthesised and isolated, complex 7 is 
stable in CH2Cl2 and X-ray quality crystals can be grown by slow 90 
evaporation of this solvent. Bond angles around the metal centre 
are 129.51(3)° for Cl1–Fe1–Cl2 and 116.50(2)° for P1–Fe1–P2. 
There is an unsymmetrical bonding angle observed at the 
phosphines where P1–Fe1–Cl1 is 96.48(2)° and P2–Fe1–Cl1 is 
substantially wider at 103.04(2)°. In contrast the bond angles at Cl2 95 
are far more symmetrical (P1–Fe1–Cl2 is 106.90(3)° and P2–Fe1–
Cl2 is 105.16(2))°. There is also a slight lengthening of the Fe1–
Cl2 bond (2.2513(6) Å versus 2.2340(7) Å for Fe1–Cl1). The Fe–
Cl and Fe–P bond lengths are consistent with those observed for 
similar four-coordinate Fe (II) complexes reported in the literature. 100 
10 
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Fig. 2. X-ray crystal structure of complex 7 (thermal ellipsoids set at 50%). 
Selected bond lengths (Å) Fe1–Cl1 2.2340(7); Fe1–Cl2 2.2513(6); Fe1–P1 
2.4415(7); Fe1–P2 2.4656(8); P1–C1 1.828(2); P1–C7 1.829(2); P1–C13 
1.832(2); P2–C21 1.831(2); P2–C27 1.824(2); P2–C33 1.833(2); C13–C14 
1.534(4); C33–C34 1.534(3). Selected bond angles (°): Cl2–Fe1–Cl1 5 
129.51(3); Cl2–Fe1–P1 106.90(3); Cl1–Fe1–P2 103.04(2); Cl2–Fe1–P2 
105.16(2); Cl1–Fe1–P1 96.48(2); P2–Fe1–P1 116.50(2). 
 
Given the optimum ligand stoichiometry necessary for the Negishi 
cross-coupling (six equivalents per iron centre, Table 1, Entry 3), 10 
we attempted to prepare the octahedral complex (8) where four 
equivalents of phosphine are used per equivalent of FeCl2·THF1.5. 
This would allow us to evaluate the effectiveness of in situ catalyst 
preparation versus the use of a pre-synthesised complex. 
Formation of the octahedral complex is not conclusive: a complex 15 
forms within minutes in dry, degassed acetone and is recrystallized 
to give an off-white powder, with micro-analytical data of the bulk 
sample consistent with formation of the desired octahedral 
complex, however, after several single crystal X-ray analyses the 
structure is consistently revealed to be identical to that of 7. This 20 
result is perhaps unsurprising as, to the best of our knowledge, no 
examples of octahedral Fe(II) complexes exist which are ligated by 
four PR3 ligands and two chlorides.11 Investigation of the 
efficiency with which complex 7 carries out the cross-coupling of 
benzyl bromide and diphenyl zinc reinforces that the quantity of 25 
phosphine in the catalytic mixture is important even with a discrete 
mononuclear complex: only 32% 6a forms with 5 mol% complex 
7.  
We next proceeded to explore the substrate scope using 2 as the 
pro-ligand. We also continued to use in situ catalyst generation 30 
(Table 1, Entry 3) due to ease of handling and inability to 
conclusively form complex 8. A range of benzyl bromides are 
tolerated in the reaction including electron donating (Table 2, 
Entries 2 and 6) and electron withdrawing substrates (Table 2, 
Entry 5). The power of the iron catalysed Negishi cross-coupling 35 
is demonstrated by halogen-substituted benzyl bromides (Entries 4 
and 7), where under palladium catalysed cross-coupling we would 
anticipate transfer of the aryl group from the diaryl zinc to the 
aromatic fragment of the benzyl bromide, thus forming a biaryl 
motif. With iron catalysis we observe complementary reactivity, 40 
where there is no evidence for biaryl formation and no indication 
that dehalogenation is taking place. The elegant nature of iron 
catalysis is further demonstrated by substrates containing β-
protons; allyl and isopropyl bromides couple to benzyl bromide in 
good yield (Entries 8 to 10) without undergoing β-hydride 45 
elimination (a major deactivation pathway observed during 
palladium catalysis). Unfortunately, steric bulk proves to be 
limiting when tert-butyl bromide is used in catalysis, with no 
product being formed.  
 50 
Table 2: Alkyl bromide substrate scope in the iron-catalysed Negishi 
cross-coupling  
Entry Bromide Product  
Spec. 
Yield 
(%)a 
1 
  
6a 74 
2 
  
6b 51 
3 
  
6c 60 
4 
  
6d 67 
5 
  
6e 51 
6 
  
6f 72 
7 
  
6g 85 
8 
  
6h 43 
9 
 
 
6i 47 
10 
 
 
6j 44 
11 
 
 
 
6k 
 
60 
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6l 
 
0 
General reaction conditions: PhMgBr (670 μl, 3 M solution in Et2O), ZnCl2 
(136 mg, 1 mmol) in THF (0.5 mL) then toluene (4 mL) and alkyl bromide 
(1 mmol). FeCl2 (6 mg, 5 mol%) and 2 (87 mg, 30 mol%) in toluene (3 
mL), 45 °C, 14 h. a Determined by 1H NMR using 1,3,5-trimethoxybenzene 
as an analytical standard, see experimental section for methodology and 5 
isolated yield. 
 
Varying the electronic properties was also investigated (Scheme 
2). It is interesting to note that when synthesising 6b and 6f, 
irrespective of whether the methoxy or fluoride group originates 10 
from the benzyl bromide or diaryl zinc reagent, the spectroscopic 
yields are very similar (compare Table 2, Entries 2 and 6 to Scheme 
2). Moderate yields of di-functionalised diarylmethane motif are 
obtained when using a 4-methoxy diaryl zinc reagent (Scheme 2, 
9a and 9b). It should also be noted that when alkyl zinc reagents 15 
were used, for example diethyl zinc and allyl zinc, no coupling to 
benzyl bromide occurs (only unreacted benzyl bromide is observed 
by 1H NMR spectroscopy). In these cases, the zinc reagent was 
added to the iron solution at low temperature (addition at both −78 
°C and 0 °C was attempted), along with RT and 45 °C (closed 20 
system) reactions for 14 h. 
Scheme 2: Negishi cross-coupling varying the diaryl zinc reagent 
(spectroscopic yield, see experimental section for isolated yield). 
 
Conclusions 25 
We have prepared simple monophosphines using HP methodology 
developed in our own laboratory. These phosphines, in the 
presence of FeCl2, competently catalyse the Negishi cross-
coupling of alkyl bromides and diaryl zinc reagents. This is a rare 
example of a monophosphine being used to carry out such a 30 
transformation and indeed we have demonstrated that PPh3 in the 
presence of FeCl2 is similarly proficient. In situ catalyst 
preparation proves to be the easiest method to facilitate the 
transformation, however, the air-sensitive four-coordinate 
complex 7 was also isolated and characterised by X-ray 35 
crystallography.  
Experimental 
General considerations 
Reagents were purchased from Sigma Aldrich and used without 
further purification. Solvents were dried over CaH2 or Na (reflux), 40 
distilled and then degassed using three freeze-pump-thaw cycles. 
NMR data was collected at 250, 300, 400 or 500 MHz on Bruker 
instruments in CDCl3 at 293 K and referenced to residual protic 
solvent or TMS. Spectroscopic yields were calculated from the 
distinctive methylene peak of the products (~ 4 ppm) using 0.1 45 
mmol of 1,3,5-trimethoxybenzene as the analytical standard. UV-
vis spectrum was collected using a 10 μM solution of 7 in CH2Cl2. 
 
General method for the synthesis of 1.  
Following the literature method,[4] Fe(OAc)2 (109 mg, 0.6 mmol, 50 
1 eq) was weighed into a flask and dissolved in ethanol (5 mL). A 
solution of N,N’-bis(salicylidene)ethylenediamine (200 mg, 0.7 
mmol, 1.2 eq) in ethanol (10 mL) was then added forming a red 
solution. The mixture was then stirred at 80 °C for 2 h. The flask 
was allowed to cool to RT before filtering the solid and subsequent 55 
washing with ethanol. The dark red solid was dried under vacuum 
for 2 hours. 
 
General method for the synthesis of phosphines 2 to 5.  
1 (8 mg, 0.2 mol%) was weighed into a Schlenk tube under an inert 60 
atmosphere. CH3CN (5 mL) was added followed by styrene (0.86 
mL, 7.5 mmol, 1 eq) and diphenylphosphine (1.04 mL, 6 mmol, 
0.8 eq). After stirring at RT for 48 h, the Schlenk tube was placed 
under vacuum to remove the excess styrene and solvent. The 
product was isolated by column chromatography (2% 65 
EtOAc/pentane). The phosphines have been isolated and analysed 
previously.5 
 
General method for Negishi reaction to form cross-coupled 
products 6a to 6k.  70 
PhMgBr (670 μL, 2 mmol, 3 M solution in Et2O) was added to a 
solution of ZnCl2 (136 mg, 1 mmol) in THF (0.5 mL) and stirred 
under N2 for 30 min. Toluene (4 mL) was added, followed by the 
appropriate benzyl bromide (1 mmol). The mixture was transferred 
by cannula to a stirred solution of FeCl2 (6 mg, 5 mol%) and 75 
phosphine (0.3 mmol) in toluene (1 mL), washing the ZnPh2 
solution through with toluene (2 mL). The reaction was stirred at 
45 °C for 14 h, quenched with H2O, extracted into EtOAc and dried 
over MgSO4. 1,3,5-Trimethoxybenzene (0.1 mmol, 10 mol%) was 
added to the dried, filtered EtOAc solution, this was then 80 
concentrated and an NMR sample prepared by diluting the whole 
sample with 1 mL CDCl3, an aliquot was removed and further 
diluted with CDCl3 prior to analysis by 1H NMR. Compounds were 
isolated by column chromatography (100% pentane to 5% 
EtOAc/pentane).  85 
 
General method for the synthesis of 7 and 8.  
FeCl2·THF1.5 (17 mg, 0.064 mmol) and 2 (0.128 mmol or 0.257 
mmol) were mixed in a vial in an argon filled glovebox. Dry, 
degassed acetone (1 mL) was added and the reaction mixture 90 
stirred for 4 h. During this time the solution turned yellow followed 
by precipitation of an off-white solid. The solution was cooled to 
−30 °C for 15 minutes then the supernatant was removed, the 
precipitate was washed with a further 2 × 1 mL cold acetone then 
dissolved in CH2Cl2, filtered through a pipette plugged with glass 95 
paper and crystals grown by slow evaporation of the solvent. NMR 
data are consistent with the formation of paramagnetic complexes. 
 
Analysis data for products 
Compound 6a, Table 2, Entry 1 100 
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Colourless oil, 102 mg (61%). 1H NMR (250 MHz; 298 K; CDCl3) 
δ 7.30-7.14 (m, 10H), 3.97 (s, 2H); 13C{1H} NMR (63 MHz; 298 
K; CDCl3) δ 141.2, 128.9, 128.5, 126.1, 41.9; IR (neat) ν 3060, 
3032, 2929, 1595, 1476 cm-1. Data matches that of a commercial 
sample (CAS: 101-81-5). 5 
 
Compound 6b, Table 2, Entry 2 
Colourless oil, 98 mg (49%). 1H NMR (250 MHz; 298 K; CDCl3) 
δ 7.33-7.29 (m, 2H), 7.28-7.22 (m, 3H), 7.16 (d, J 8.4 Hz, 2H), 
6.87 (d, J 8.4 Hz, 2H), 3.94 (s, 2H), 3.79 (s, 3H); 13C{1H} NMR 10 
(63 MHz; 298 K; CDCl3) δ 157.9, 141.6, 133.3, 129.9, 128.8, 
128.4, 126.0, 113.9, 55.3, 41.0; IR (neat) ν 3025, 2860, 1594, 1494, 
1437 cm-1. Data matches literature reports.12 
 
Compound 6c, Table 2, Entry 3 15 
Colourless oil, 88 mg (49%). 1H NMR (250 MHz; 298 K; CDCl3) 
δ 7.42-7.32 (m, 2H), 7.32-7.22 (m, 3H), 7.22-7.12 (m, 4H), 4.03 
(s, 2H), 2.40 (s, 3H); 13C{1H} NMR (63 MHz; 298 K; CDCl3) δ 
141.5, 138.1, 135.6, 129.2, 128.9, 128.9, 128.5, 126.1, 41.6, 21.1; 
IR (neat) ν 3022, 2850, 1595, 1491 cm-1. Data matches literature 20 
reports.2i,8 
 
Compound 6d, Table 2, Entry 4 
White solid, 85 mg (34%). 1H NMR (250 MHz; 298 K; CDCl3) δ 
7.48-7.16 (m, 9H), 3.94 (s, 2H); 13C{1H} NMR (63 MHz; 298 K; 25 
CDCl3) δ 140.4, 139.9, 131.5, 130.6, 128.9, 128.5, 126.3, 119.8, 
41.6; IR (neat) ν 3025, 2920, 1598, 1484 cm-1. Data matches 
literature reports.2i,8 
 
Compound 6e, Table 2, Entry 5 30 
Colourless oil, 112 mg (47%). 1H NMR (250 MHz; 298 K; CDCl3) 
δ 7.58 (d, J 8.0 Hz, 2H), 7.38-7.20 (m, 7H), 4.06 (s, 2H); 13C{1H} 
NMR (63 MHz; 298 K; CDCl3) δ 145.3, 140.0, 129.2, 128.9, 
128.7, 128.2 (q, J 33 Hz), 126.5, 125.4 (q, J 4 Hz), 124.4 (q, J 270 
Hz), 41.7; IR (neat) ν 3031, 2931, 1595, 1481 cm-1. Data matches 35 
literature reports.2i,8 
 
Compound 6f, Table 2, Entry 6 
Colourless oil, 127 mg (69%). 1H NMR (500 MHz; 298 K; CDCl3) 
δ 7.28 (t, J 7.3 Hz, 2H), 7.21-7.18 (m, 5H), 6.96 (t, J 8.8 Hz, 2H), 40 
3.93 (s, 2H); 13C{1H} NMR (125 MHz; 298 K; CDCl3) δ 161.3 (d, 
J 244.2 Hz), 140.7, 136.5 (d, J 2.9 Hz), 130.0 (d, J 7.6 Hz), 128.8, 
128.5, 126.2, 115.4 (d, J 21.0 Hz), 41.0; IR (neat) ν 3035, 2944, 
1589, 1489 cm-1. Data matches literature report.13 
 45 
Compound 6g, Table 2, Entry 7 
Colourless oil, 155 mg (78%). 1H NMR (250 MHz; 298 K; CDCl3) 
δ 7.30-7.12 (m, 6H), 6.79-6.70 (m, 3H), 3.91 (s, 2H), 3.71 (s, 3H); 
13C{1H} NMR (63 MHz; 298 K; CDCl3) δ 159.9, 142.9, 139.9, 
129.5, 128.9, 128.5, 126.2, 121.4, 114.9, 111.4, 55.1, 42.1; IR 50 
(neat) ν 3030, 2973, 1595, 1496 cm-1. Data matches literature 
reports.14  
 
Compound 6h, Table 2, Entry 8 
Colourless oil, 98 mg (40%). 1H NMR (250 MHz; 298 K; CDCl3) 55 
δ 7.57 (d, J  9.0 Hz, 1H), 7.37-7.01 (m, 8H), 4.12 (s, 2H); 13C{1H} 
NMR (63 MHz; 298 K; CDCl3) δ 140.4, 139.6, 132.8, 131.1, 
128.9, 128.5, 127.9, 127.6, 126.2, 124.9, 41.7; IR (neat) ν 3018, 
2920, 1591, 1513, 1447 cm-1. Data matches literature reports.15 
 60 
Compound 6i, Table 2, Entry 9 
Colourless oil, 84 mg (45%). 1H NMR (250 MHz; 298 K; CDCl3) 
δ 7.38-7.02 (m, 10H), 2.92 (s, 2H); 13C{1H} NMR (63 MHz; 298 
K; CDCl3) δ 141.8, 128.4, 128.3, 125.9, 37.0; IR (neat) ν 3029, 
2930, 1595, 1481 cm-1. Data matches that of a commercial sample 65 
(CAS: 103-29-7). 
 
Compound 6j, Table 2, Entry 10 
Colourless oil, 48 mg (40%). 1H NMR (250 MHz; 298 K; CDCl3) 
δ 7.33-7.18 (m, 5H), 6.06-5.93 (m, 1H), 5.13-5.05 (m, 2H), 3.40 70 
(d, 2H, J 6.5 Hz); 13C{1H} NMR (63 MHz; 298 K; CDCl3) δ 148.8, 
128.3, 126.4, 125.8, 34.1, 24.0; IR (neat) ν 3028, 2902, 1639, 1494 
cm-1. Data matches that of a commercial sample (CAS: 300-57-2). 
 
Compound 6k, Table 2, Entry 11 75 
Colourless oil, 68 mg (57%). 1H NMR (250 MHz; 298 K; CDCl3) 
δ 7.45-7.30 (m, 5H), 3.03 (septet, 1H, J 6.9 Hz), 1.40 (d, 6H, J 6.9 
Hz); 13C{1H} NMR (63 MHz; 298 K; CDCl3) δ 140.0, 137.4, 
128.6, 128.4, 126.0, 115.7, 40.1; IR (neat) ν 3028, 2960, 1494, 
1464 cm-1. Data matches that of a commercial sample (CAS: 98-80 
82-8). 
 
Complex 7 
Isolated as a white powder (35 mg, 77%). 1H NMR (500 MHz; 298 
K; CD2Cl2) δ 13.42 (br), 7.55 (br), 7.14 (br), 0.85 (br), 0.12 (br), -85 
0.92 (br); 13C{1H} NMR (125 MHz; 298 K; CD2Cl2) δ 173.4, 
148.7, 135.1, 128.5, 128.3, 126.4, 31.6, 31.0, -0.5; elemental 
analysis: C 67.9, H 5.4 (calcd); C 68.1, H 5.0 (obs.); m.p. 164 °C 
(decomp.); IR (solid) ν 3054 (w), 3023 (w), 1602 (w), 1583 (w), 
1484 (s), 1433 (s), 1238 (br), 1097 (s), 748 (s), 738 (s), 732 (s), 90 
723 (s). 
 
Crystal Data for C40H38Cl2FeP2 (7).  
M = 707.39,  = 0.71073 Å, triclinic, space group P-1, a = 
9.4059(4), b = 10.4593(5), c = 19.1213(8)Å, α = 89.049(4),  95 
= 84.880(4), γ = 68.014 o, U  = 1737.08(13) Å3, Z = 2, Dc  = 
1.352 g cm-3,  = 0.708 mm-1, F(000) = 736.  Crystal size = 
0.3550 × 0.2201 × 0.1414 mm, unique reflections = 7961 [R(int) 
= 0.0294], observed reflections [I>2I)] = 6167, 
data/restraints/parameters = 7961/0/406. Observed data; R1 = 100 
0.0432, wR2 = 0.0814.  All data; R1 = 0.0638, wR2 = 0.0886. 
Max peak/hole = 0.443 and −0.341 eÅ-3, respectively. CCDC 
1035920. 
 
Compound 6b, Scheme 2 105 
Colourless oil, 99 mg (50%). Data matches literature reports.11  
 
Compound 6f, Scheme 2 
Colourless oil, 117 mg (63%). Data matches literature reports.12 
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Compound 9a, Scheme 2 
Colourless oil, 102 mg (48%). 1H NMR (500 MHz; 298 K; CDCl3) 
δ 7.14-7.08 (m, 6H), 6.86-6.84 (m, 2H), 3.90 (s, 2H), 3.79 (s, 3H), 
2.33 (s, 3H); 13C{1H} NMR (125 MHz; 298 K; CDCl3) δ 157.7, 
138.6, 135.1, 133.6, 129.7, 129.2, 128.8, 113.7, 55.0, 40.4, 115 
20.8. Data matches literature reports.11c  
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Compound 9b, Scheme 2 
White solid, 113 mg (41%). 1H NMR (500 MHz; 298 K; CDCl3) δ 
7.50 (d, J 8.3 Hz, 2H), 7.08-7.01 (m, 4H), 6.85 (d, J 8.3 Hz, 2H), 
3.84 (s, 2H), 3.78 (s, 3H); 13C{1H} NMR (125 MHz; 298 K; 
CDCl3) δ 158.4, 140.3, 132.6, 131.0, 130.1, 129.4, 119.4, 113.8, 5 
54.8, 40.2; m.p. 88 °C. Data matches literature reports.16 
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